PL1610613T3 - Miejscowe preparaty weterynaryjne przeciw robakom - Google Patents

Miejscowe preparaty weterynaryjne przeciw robakom

Info

Publication number
PL1610613T3
PL1610613T3 PL04758886T PL04758886T PL1610613T3 PL 1610613 T3 PL1610613 T3 PL 1610613T3 PL 04758886 T PL04758886 T PL 04758886T PL 04758886 T PL04758886 T PL 04758886T PL 1610613 T3 PL1610613 T3 PL 1610613T3
Authority
PL
Poland
Prior art keywords
veterinary formulations
topical anthelmintic
topical
anthelmintic veterinary
formulations
Prior art date
Application number
PL04758886T
Other languages
English (en)
Inventor
Mark D. Soll
Krishan Kumar
Robert P. Waranis
Natalya Shub
Original Assignee
Merial, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33159788&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1610613(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merial, Inc. filed Critical Merial, Inc.
Publication of PL1610613T3 publication Critical patent/PL1610613T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL04758886T 2003-04-04 2004-04-05 Miejscowe preparaty weterynaryjne przeciw robakom PL1610613T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46062703P 2003-04-04 2003-04-04

Publications (1)

Publication Number Publication Date
PL1610613T3 true PL1610613T3 (pl) 2017-06-30

Family

ID=33159788

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04758886T PL1610613T3 (pl) 2003-04-04 2004-04-05 Miejscowe preparaty weterynaryjne przeciw robakom

Country Status (17)

Country Link
US (1) US6991801B2 (pl)
EP (1) EP1610613B1 (pl)
JP (1) JP2006522154A (pl)
AU (2) AU2004228041B2 (pl)
BR (1) BRPI0409185B1 (pl)
CA (1) CA2521268C (pl)
CY (1) CY1120462T1 (pl)
DK (1) DK1610613T3 (pl)
ES (1) ES2620413T3 (pl)
HU (1) HUE032009T2 (pl)
LT (1) LT1610613T (pl)
MX (1) MXPA05010659A (pl)
NZ (1) NZ542955A (pl)
PL (1) PL1610613T3 (pl)
PT (1) PT1610613T (pl)
WO (1) WO2004089239A2 (pl)
ZA (1) ZA200508264B (pl)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
KR100595446B1 (ko) * 2004-01-19 2006-07-03 삼성전자주식회사 디스플레이장치
US7666444B2 (en) * 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
MX2007002961A (es) * 2004-09-16 2008-03-13 Bayer Healthcare Ag Fromulaciones aplicables dermicamente para el tratamiento de enfermedades cutaneas en animales.
CN101048139A (zh) * 2004-10-28 2007-10-03 艾德克斯实验室公司 药物活性化合物的控释组合物
DE102004053964A1 (de) * 2004-11-09 2006-05-11 Bayer Healthcare Ag Mittel gegen Demodikose
WO2006061214A1 (en) * 2004-12-10 2006-06-15 Bayer Healthcare Ag Anthelmintic composition
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
US20060293260A1 (en) * 2005-05-24 2006-12-28 Wyeth Useful high load concentrate compositions for control of ecto-and endo-parasites
CA2622002A1 (en) * 2005-09-26 2007-04-05 Piedmont Pharmaceuticals Llc Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into the middle ear
AU2006295236A1 (en) * 2005-09-26 2007-04-05 Piedmont Pharmaceuticals Llc Methods for treatment and prevention of otitis media using chemical penetration enhancers to facilitate transmembrane drug delivery into the middle ear
US8114440B2 (en) 2005-11-16 2012-02-14 Idexx Laboratories Inc. Pharmaceutical compositions for the administration of aptamers
US7754679B2 (en) 2005-11-16 2010-07-13 Idexx Laboratories, Inc. Pharmaceutical compositions for the administration of aptamers
US7700614B2 (en) * 2005-12-14 2010-04-20 Abbott Laboratories One pot synthesis of tetrazole derivatives of rapamycin
AU2006100657C4 (en) * 2006-05-15 2009-09-10 Wyeth Stabilised formulation
ZA200901429B (en) 2006-09-01 2010-06-30 Du Pont Local topical administration formulations containing indoxacarb
US8828960B2 (en) 2007-07-17 2014-09-09 Idexx Laboratories, Inc. Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds
TW200924647A (en) * 2007-08-30 2009-06-16 Schering Plough Ltd Local topical administration formulations containing fipronil
FR2922108A1 (fr) 2007-10-11 2009-04-17 Virbac Sa Utilisation d'un derive de 1-n-(halo-3-pyridylmethyle)-n-methylamino-1-alkylamino -2- nitroethylene pour la preparation d'une composition pharmaceutique veterinaire pour lutter contre les puces
ES2693696T3 (es) * 2007-11-26 2018-12-13 Merial, Inc. Sistemas de disolventes para formulaciones de unción dorsal continua para combatir parásitos
FR2925337B1 (fr) * 2007-12-21 2010-01-15 Virbac Composition pharmaceutique contenant un derive de n-phenylpyrazole et du glycofurol, utilisation pour la preparation d'un medicament veterinaire topique pour lutter contre les puces
BRPI0802255A2 (pt) * 2008-06-17 2010-03-16 Sespo Ind E Com Ltda composição de uso tópico para controle de ectoparasitos em cães e gatos
AU2010224685A1 (en) 2009-03-18 2011-11-03 Fidopharm, Inc. Parasiticidal formulation
GB0905365D0 (en) 2009-03-27 2009-05-13 Norbrook Lab Ltd A topical parasiticide composition
US8313752B2 (en) * 2009-04-14 2012-11-20 Merial Limited Macrocyclic lactone combination compositions, vaccines and methods for producing same
US8980896B2 (en) * 2009-12-17 2015-03-17 Merial, Inc. Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
AU2016247183B2 (en) * 2010-04-02 2018-03-29 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising multiple active agents, methods and uses thereof
UA108641C2 (uk) * 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
AU2015202084B2 (en) * 2010-04-02 2016-07-28 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising multiple active agents, methods and uses thereof
WO2012089623A1 (en) * 2010-12-27 2012-07-05 Intervet International B.V. Topical localized isoxazoline formulation comprising glycofurol
CN102221293B (zh) * 2011-06-08 2013-05-08 大连理工大学 一种熔炼坩埚用涂层的制备方法
US20120329832A1 (en) * 2011-06-27 2012-12-27 Jean Delaveau Novel Insect-Repellent Coumarin Derivatives, Syntheses, and Methods of Use
PT2755473T (pt) 2011-09-12 2019-03-25 Boehringer Ingelheim Animal Health Usa Inc Composições parasiticidas compreendendo um agente ativo de isoxazolina, métodos e suas utilizações
WO2014098619A1 (en) * 2012-12-18 2014-06-26 Donaghys Industries Limited Transdermal parasiticidal formulations
US9049860B2 (en) * 2013-04-17 2015-06-09 The Hartz Mountain Corporation Ectoparasiticidal methods
NZ701697A (en) 2014-03-24 2016-05-27 Donaghys Ltd Stable veterinary anthelmintic formulations
AR104691A1 (es) * 2016-05-18 2017-08-09 Labyes De Uruguay S A Composición veterinaria de imidacloprid, moxidectina y praziquantel de administración tópica cutánea (spot on) para tratamiento y prevención de las ecto y endoparasitosis que afectan a los perros
GB2552952B (en) * 2016-08-12 2020-03-04 Norbrook Lab Ltd Moxidectin topical liquid formulations
WO2019054967A2 (en) * 2017-03-15 2019-03-21 Verano Ilac Sanayi Ve Ticaret Anonim Sirketi VETERINARY COMPOSITION TO BE POURED COMPRISING EPRINOMECTIN
PL3595441T3 (pl) 2017-03-17 2023-12-04 Krka, D.D., Novo Mesto Stabilna kompozycja weterynaryjna do stosowania miejscowego
WO2019025561A1 (en) * 2017-08-03 2019-02-07 Universität Regensburg FUEL FROM RENEWABLE RESOURCES
JP7274479B2 (ja) * 2017-11-23 2023-05-16 セバ・サンテ・アニマル 寄生虫の寄生を治療するためのモキシデクチンを含有する組成物
WO2019157241A1 (en) 2018-02-08 2019-08-15 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
KR102188378B1 (ko) * 2018-11-02 2020-12-08 녹십자수의약품(주) 셀라멕틴을 포함하는 구충제 조성물
CN110835471B (zh) * 2019-11-19 2021-06-18 广州市汇合彩颜料有限公司 一种用于研磨颜料的低挥发有机溶剂制备方法
US10857151B1 (en) * 2020-02-21 2020-12-08 Villya LLC Treatment of female genital schistosomiasis
CN113209012A (zh) * 2021-06-04 2021-08-06 湖南伟达科技有限公司 一种阿维菌素透皮溶液及其制备方法
WO2024158694A1 (en) 2023-01-23 2024-08-02 Villya LLC Compositions and methods for improving the solubility of erectile dysfunction therapeutics

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57139012A (en) * 1981-02-23 1982-08-27 Sankyo Co Ltd Anthelmintic composition
GB2221621A (en) * 1988-08-12 1990-02-14 Merck & Co Inc Synergistic antiparasitic combinations of avermectin and pyrantel
US5439924A (en) * 1991-12-23 1995-08-08 Virbac, Inc. Systemic control of parasites
BG61064B1 (bg) * 1993-08-12 1996-10-31 Илия Илиев Лекарствено средство за обезпаразитяване на животни
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten
AUPM969994A0 (en) * 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
NZ272574A (en) * 1995-07-14 1999-02-25 Lilly Eli & Co Nz Ltd Aqueous base suspension concentrate containing at least one ionophore antibiotic and wetting agent and/or a surfactant and xanthan gum optionally with a suspension agent, an antifreeze agent and an antifoaming agent; drench for veterinary treatment
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
IE80657B1 (en) 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
US6413542B1 (en) 1996-03-29 2002-07-02 Merial Direct pour-on antiparasitic skin solution and methods for treating, preventing and controlling myasis
US5958888A (en) 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions
EP0959891A1 (en) * 1996-07-30 1999-12-01 Ashmont Holdings Limited Anthelmintic formulations
US6426333B1 (en) 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
FR2753377B1 (fr) * 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
DE19654079A1 (de) * 1996-12-23 1998-06-25 Bayer Ag Endo-ekto-parasitizide Mittel
US6042775A (en) 1998-01-29 2000-03-28 Tm Industrial Supply, Inc. Silver reclamation system
US6239112B1 (en) 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
EA004251B1 (ru) * 1999-08-12 2004-02-26 Эли Лилли Энд Компани Эктопаразитицидные водные суспензионные препараты спинозинов
EP1215964A4 (en) * 1999-09-22 2002-11-05 Ashmont Holdings Ltd POUR-ON COMPOSITION FOR SHEEP
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
US6207179B1 (en) * 2000-05-18 2001-03-27 Phoenix Scientific, Inc. Parasiticidal formulation for animals and a method of making this formulation
GB0108485D0 (en) * 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
ES2365993T5 (es) * 2001-09-17 2020-06-25 Elanco Us Inc Formulaciones pesticidas
ES2439725T3 (es) * 2001-10-05 2014-01-24 Rubicon Scientific Llc Piensos para animales que incluyen principios activos
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations

Also Published As

Publication number Publication date
DK1610613T3 (en) 2017-02-27
HUE032009T2 (en) 2017-09-28
EP1610613A2 (en) 2006-01-04
WO2004089239A3 (en) 2004-11-25
JP2006522154A (ja) 2006-09-28
AU2004228041B2 (en) 2009-06-04
BRPI0409185A (pt) 2006-04-11
BRPI0409185B1 (pt) 2018-05-15
LT1610613T (lt) 2017-03-27
PT1610613T (pt) 2017-03-07
CA2521268C (en) 2012-10-16
AU2004228041A1 (en) 2004-10-21
CA2521268A1 (en) 2004-10-21
AU2009212762A1 (en) 2009-09-17
ZA200508264B (en) 2007-03-28
CY1120462T1 (el) 2019-07-10
EP1610613B1 (en) 2016-12-28
WO2004089239A2 (en) 2004-10-21
US6991801B2 (en) 2006-01-31
EP1610613A4 (en) 2012-05-02
NZ542955A (en) 2008-07-31
MXPA05010659A (es) 2005-12-12
ES2620413T3 (es) 2017-06-28
US20040198676A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
LT1610613T (lt) Vietinio taikymo antihelmintinės veterinarinės kompozicijos
ZA200410250B (en) Anthelmintic oral homogeneous veterinary pastes
IL162642A0 (en) Formulations
GB0210397D0 (en) Pharmaceutical formulations
IL172824A0 (en) Pharmaceutical formulations
PL374347A1 (pl) Stałe formulacje farmaceutyczne zawierające telmisartan
GB0302671D0 (en) Pharmaceutical formulations
SI1513514T1 (sl) Topične formulacije hidroksimatairezinola
AP2005003346A0 (en) Topical anti-infective formulations
EP1648364A4 (en) PHARMACEUTICAL COMPOSITIONS FOR TOPICAL APPLICATION
GB0323701D0 (en) Formulations
GB0218930D0 (en) Pharmaceutical formulations
GB0316206D0 (en) Pharmaceutical formulation
GB0302672D0 (en) Pharmaceutical formulations
SI1680088T1 (sl) Formulacija s prikritim okusom, ki vsebuje klaritromicin
GB2413764B (en) Anthelmintic composition
GB0316341D0 (en) Pharmaceutical formulations
IL174308A0 (en) Therapeutic formulations
GB2403407B (en) Palatable oral anthelmintic composition
GB0307765D0 (en) Tissue-adhesive formulations
PL364014A1 (pl) Kompozycje weterynaryjne
GB0214147D0 (en) Formulations
GB0316335D0 (en) Pharmaceutical formulations
GB0310881D0 (en) Pharmaceutical formulation
GB0324912D0 (en) Pharmaceutical formulations